biontech up nearly 10%, pfizer adding 2.5%.eady this year. the company expects $33.5 billion in revenues from its covid vaccine this year. joining me now to discuss, ronnie als it's good to have you. a lot of investors have been trading these vaccine names, and the price action today maybe tells you that there was not fully priced in just how many mandates we're starting to see as i mentioned from the armed forces to new york city public schools to new jersey public schools, you name it what would you say to people about the stocks >> it seems a lot of those have good news. we now have the u.s. and the rest of the world already committing to buy those vaccines from pfizer and moderna at a higher price than the first wave of vaccination, about 10%, 20% we don't know if there will be a need for additional boosting beyond the current boosting that is being discussed and it seems like a lot of that seems to be a bit priced in. to believe there's further offset, you need to believe covid will be with us and you can be vaccinated wit

amy: as the fda fully authorized the pfizer-biontech covid-19 vaccine, doctors without borders is calling on the companies to immediately share the vaccine technology with manufacturers in africa where less than 2% of the population is fully vaccinated. in andrew cuomo commute the sentence a former weather underground member david gilbert . it was one of his last acts before he resigned as new york governor at midnight. we will speak to david gilbert's wyer. >> in david's case, there someone who was incredibly remorseful for the harmause inhe lives lost and someone thin the confines prison had invoked himself to making the world better for everyone. amy: plus, we speak to ben jealous of people for the american way about what he and other voting rights activists will be risking arrest outside the white house today will demand president biden call on the senate to eliminate the filibuster in order to pass voting rights legislation. all that and more, coming up. welcome to democracy now!, democracynow.org, the war and peace report. i'm amy goodman. leaders of the g7 group of wealthy nations

coming up, pfizer and biontech's vaccine gets full approval from the fda.ll have details to follow. this is bloomberg. ♪ ritika: it is time for the bloomberg business flash. i'm ritika gupta. bitcoin has gone over have to thousand dollars for the first time since mid-may -- over $50,000 for the first time since mid-may. the total crypto market has seen its value rise almost $1 trillion in the last month. companies around the world are so flush with cash that they are racing to bring back dividends, according to a study from data henderson investors. payouts are expected to reach almost $1 trillion this year, the second highest total ever. dividends will hit prepend them in -- pre-pandemic highs within 12 months. pfizer has agreed to by all the shares of cancer drug maker trillion, valued at a 118% premium to trillion's price. that is your bloomberg business flash. guy: the fda has granted full approval for the pfizer/biontech covid vaccine. bloomberg senior stocks editor dave wilson has more. dave: you are talking about a vaccine that has been sold in the u

pfizer biontech getting full fda approval.as been a surge in infections, a big concern for investors. of course, all of these things will be front and center in jackson hole this week, which is also feeling the pain of the pandemic and the spread of delta. michael mckee is our policy correspondent. by the time we get to jackson hole, it will have a different feel than just a couple of weeks ago. mike: we thought the fed would be talking about when they might taper, but now it may be about whether they hold off because of what has happened with covid. cases in wyoming rising significantly. the county in which the symposium is held is going to code red. they say you cannot have meetings and everyone needs to be masked, you have to be social distanced. the kansas city fed decided to call it off, which is interesting. the fed had set us up for the idea that we may see a change in the operations. in their most recent meeting, they noted participants saw the path of the economy would depend on the course of the virus, risks to the e

biontech cash push it needs.buts on the exchange in just a few minutes. this is the second-largest largest korean debut on record. let's bring in our asian tech reporter. what are we expecting from the listing today? ? . crafton -- today? >> krafton is set to raise $3.8 billion and be the country's second largest ipo. 4981 per piece. there has been some concern over the high valuation. based on the price, it would become the biggest gaming company with more than $20 billion of market cap. typically, there is a first day trading pop in korea driven by retail investors who snap up shares for quick returns. qualcomm went for 79% on its first day and -- on friday and continued to rise on monday. they could gain momentum because 90% of its sales are from one title. >> what is the business outlook for krafton? >> the ceo told us in an interview that the company is not going to stay as a one-hit wonder. the company is basically transforming itself to become an entertainment company with cartoons and movies. investors ar

but our major flyers are serum institute and pfizer and biontech.um institute of india is contributing almost 100 20 million doses per month. we're expecting it will further increase to around 150 million doses a month. and the other one should also come up rapidly. because of many glitches, there have been some --. in september, we expect it should be providing us about 120 million doses. then we have the russian vaccine which is manufactured by companies within india. that, plus zyko vd, and another two manufacturers. one which india has done advance order. and another is an indian mrna vaccine, genoa. that should also be available. these companies are in phase three but they are already preparing their vaccines. so by the end of this year, we expect about 1.8 billion doses. august is already gone. so in the next four months, we should be able to have about one point one billion doses available for our people. juliette: doctor, this is increasingly becoming, as they have been mentioning in the united states, a pandemic of the unvaccinated, and the

without doubt, for both biontech and moderna, biontech only has half a share of covid-19 vaccine sales that goes through pfizer. there is no doubt that there are some years of booster sales factored into the share price. that may not be in consensus because they are two different things. there are expectations built into the stock for booster shots. that is something investors have to be wary of when investing in the stock. caroline: thank you. and now we have breaking news. talking about transparency when it comes to the vaccine, kathy woods fired for a new transparency etf -- filed for a new transparency etf. romaine: what is in it? caroline: she will be you tubing about it a minute. -- youtubeing about it in a minute. this is bloomberg. and there you have it— -woah. wireless on the most reliable network nationwide. wow! -big deal! ...we get unlimited for just $30 bucks. sweet, but mine has 5g included. relax people, my wireless is crushing it. that's because you all have xfinity mobile with your internet. it's wireless so good, it keeps one upping itself. switch to xfinity mobile an

pfizer and biontech both moving higher, pfizer 2.7%, bind tech 3% -- biontech.ts that the fda is facing pressure to fully approve pfizer and biontech's vaccine as early as this month, a move many think could help boost vaccination numbers as the delta variant fuels a fourth wave across the nation. the resurgence is also allowing all pfizer, biontech and moderna to raise prices in their latest contracts with the government. that according to the financial times. okay. so earlier this morning we started to hear all kinds of issues about this, but now we look at the delta variant, and you pair it with high gasoline prices, and that may be weighing on americans' minds as they road trip this summer. according to gasbuddy's mid-summer travel survey, 10% fewer americans are planning to take a road trip this summer than they were in may. yet demand for gasoline just hit the highest level of 2021. breaking down all the summer travel with special guest lady liberty is gerri willis. there are travel implications and investor implications here. >> reporter: you betcha. and,

regulator full approval for the pfizer biontech vaccine. president biden speaking on monday, saying this may spur mandates for employers to get their employees vaccinated. american depository up nearly 10%. the other big story, the decision by california courts to throw out that ballot decision that people voted to treat gig economy workers as contractors. interesting, what we saw initially monday, a drop in those stocks come all down. by close of play on monday, uber up more than 2.5%. it was really just doordash that struggled to negate those losses. wall street essentially saying that they expected some short-term losses, some volatility, some pressure. really, this will not move the needle much. emily: ed ludlow, thanks so much. the hotly debated california law that voters passed last november has been ruled unconstitutional. companies uber, lyft, doordash, instacart, lobbied heavily. it allows them to classify workers as contractors instead of full-time employees and benefits that come with that. california judge says this law is unenf

contessa, good morning >> brian, good morning fda amended the pfizer biontech and moderna vaccines to allo immunocompromised people to get a third dose this is the day before the advisory committee of the fda is set to vote on the vaccine guidelines for those with weakened immune systems. the rise in infections means 90% of the communities meet the threshold for indoor mask wearings new orleans and san francisco requiring for restaurants and gyms and other venues. also, breaking late yesterday, the supreme court will not block indiana university's vaccine policy that requires all students get a shot to attend classes in the fall semester the first decision on the high court on the hot-button issue. it was directed to judge amy coney barrett. she was a professor at notre dame she has experience in academia and the rig or orrigors of a ca of young people. and facebook is delaying the return to work until january of 2022 they expected a full return by october. not happening now because of the delta variant. >> i have a feeling more companies will follow suit contessa brewer, see you in a

news today with the fda full approval for pfizer and biontech. that leading to people thinking perhaps that will help with vaccine hesitancy, not to mention more vaccine mandates. haidi: president biden has been outspoken about hoping to get this full approval sooner than later. now that it is here he hopes that means more corporate skin mandate vaccines and get more people vaccinated. a lot of people hoping this will reassure people on the fence because they thought there had not been the full breadth of fda approval. we are looking ahead to how the delta variant and handling of the vaccine and virus levels play into the economic debate. shery: especially as we head to the jackson hole meeting. it has been an event where policymakers could announce new initiatives. now there are questions on whether or not chair powell's announcement last year, the new policy framework, plus inflation overshooting the 2% target for a while, could backfire, given we have so much money in fiscal stimulus, not to mention worker shortage. inflation rallying now we s

. >>> speaking of blowing through 400, moderna is trying to find some legs, jim between it and biontech, 60 billion in market cap losses the last couple of days. >> that's been brutal. i think it's now heavily shorted. it can't see because of its price maybe the meme people, the apes have not endorsed it. the apes are doing everything they can to keep a couple of other stocks in the air. they must be happy with palantir. >> the business is amazing, the stock is one of the great performers it's up 450% over the last 12 mo months just the other day i was saying it was bigger than merck. >> i don't understand why people don't buy pfizer pfizer had an awful -- now they have all kinds of money. they can buy whatever they want and therefore, eliminate the patent cliff. >> pfizer got past its 20 -year high. >> really? >> yeah. >> the 20-year viagra high. >> yeah. 20 years for pfizer, finally broke out. >> the semis are down hard. >> i like looking at a pfizer 20-year because i know it drives him crazy. >> who >> fiezer. >> it's a viagra stock i was with you, on set with you. you were making fu

pfizer and covid-19 partner biontech seeking full approval from u.s.for a booster shot for those 16 and older. the company announced they have started an application with the fda for a third dose. pfizer and biontech say they plan to complete submission of the application by the end of the week, bringing them one step closer. bloomberg has learned the latest soon-to-be released u.s. intelligence report on the origins of covid-19 is inconclusive. meanwhile, beijing warns as retaliation against those questioning whether the virus leaked from its labs. china's foreign ministry director general made the comments ahead of the report's release. he says while beijing will cooperate against the w.h.o., detractors should be prepared to accept the counter attack. israel's new prime minister will oppose u.s. led efforts to revive the iran nuclear deal during his meeting with president biden at the white house. in a new york times interview, he says he will assert his country's intentions to continue attacks on tehran's atomic program and says his coalition govern

the pfizer biontech shot was 93% effective against symptomatic infection shortly after a second dose,to 71% for the astrazeneca jab. pfizer's efficacy ebbed after similar levels. it does not diminish the viral load carried by those with the delta variant. mastercard will face the largest ever class-action file. the tribunal says the claimant is seeking around 40 alien pounds in damages can represent 46 million u.k. consumers. it stems from an eight year ruling that mastercard fees were unfair. the american company calls the claim spurious, saying it is driven by lawyers. the u.s. will offer booster shots to all vaccinated adults from september 20. it is a massive expansion of a program previously limited to those with weakened immune systems, as infections from the delta variant surged. the u.s. is facing a new wave of covid infections primarily among the unvaccinated. global news, 24 hours a day, on air and at bloomberg quicktake, powered by more than 2700 journalists and analysts in more than 120 countries. this is bloomberg. francine: let's get to your stocks to watch with joe east

gives full approval to the pfizer biontech shot. the fcc reportedly issues new disclosure requirements for chinese companies seeking to list in new york. we look at the fallout of beijing's corporate crackdowns for global investors in an exclusive interview with the msci ceo, henry fernandez. despite the challenges, we saw chinese adrs getting ground today, broad risk-on with the nasdaq composite and nasdaq 100 surging to record highs. we had more positive economic data when it came to those july existing home sales upsetting weaker pmi numbers but of course we will be watching what happens with those headlines because they came after the market close. haidi: absolutely. we are expecting more pressure when it comes to chinese adrs given that we are now seeing the fcc leaning ever harder in the regulations on chinese ceo's, wanting more transparency on how these structural setups are being made and this ongoing conversation about requiring more transparency from these companies. it does not look like we are going to see much respite

just to go back to your biontech point, i've asked the ceo and founder of biontech that question, yous that's up more than 400% since july 1st as of july 30th we reported more than 100,000 daily new cases new hospitalizations are also rising now to 6,000 people going into the hospital with covid every day. deaths have also risen since july 1st 40% to an average of more than 300 people dying of covid every day. this is not an equally distributed in terms of severe effects. we are seeing the highest effects still in parts of the country in terms of louisiana, florida, missouri. hospitalizations still highest in those areas the number of counties counted as high or substantial spread you can see is increasing. so cases are really going up almost everywhere, but where you're seeing the severest effects are the areas with the lowest hospitalization rates we had a cool graphic to show you and i'm not sure it's working. evercore isi is looking at what's happening and we're wondering if we'll see the peak in the u.s. that they're seeing in the u.k if you look at southwest missouri which is wh

pfizer and covid-19 vaccine partner biontech are seeking full approval of u.s.ators for a booster shot for people aged 16 and older. the companies already announced they started an application with the fda for a third dose. reiser and biontech say they plan to complete submission by the end of the week, bringing them one step closer to clearance. yoshihide suga has expanded the state of emergency to cover more than 70% of the population. the delta variant surge has led to a record number of cases and is straining the medical system. the curbs include the tokyo and osaka metro regions which will run until september 12. the move comes as japan hosts the paralympics and as suga's support drops to record lows. bloomberg has learned the latest soon to be released u.s. intelligence report on the origins of covid-19 is inconclusive as beijing warns a retaliation against those questioning whether the virus leaked from its labs. china's foreign director general made the comments ahead of the report's release. he says while beijing will cooperate with groups like the who,

doses six to 12 months after the second dose, that is going back for a third dose of the pfizer biontech vaccine after completing the first two doses. their partner has presented data where there is a slight drop in antibodies which is the main element of the immune response that protects us from this virus. when you take into consideration all the other factors there is some lab testing -- there is some lab testing that shows a drop in antibodies. the main thing to watch for is data from the real world, people living in the real world and seeing how these vaccines are holding up. these vaccines are still largely protective and there might be a drop from something like 95% effective to 90% effective and over several more months of vaccine manufacturers expect that to continue to gradually decline without a booster shot. 90% to 89%. the key thing to watch is around severe disease and protecting against hospitalization and death and that is where the most interesting data has come out of israel. there booster dose for people 60 years and older who are five months removed from the second do

biontech seeking approval from u.s. regulators. the company announced they had already submitted an application to the fda for a third dose. pfizer and biontech say they plan to compete for permission by the end of the week, bringing them one step closer to clearance. bloomberg has learned the latest soon to be released intelligence report on the origins of the virus is inconclusive as beijing warns of retaliation against those questioning if the virus leaked from its labs. u.s. secretary of state anthony blinken says about 1500 -- 50 and hundred americans are still in afghanistan. evacuations are about to end within the next few days. the plan is for remaining troops to pull out by president biden's a deadline of august 31. >> it is hard to overstate the complexity and danger of this effort. we are operating in a hostile environment in a city and country now controlled by the taliban with the very real possibility of an isis attack. yvonne: still ahead, the world economy's supply chain problem is getting worse. up next, we talk ab

the problem with that three-to-four week interval for pfizer, biontech and moderna au respectively ist schedule is not very good for producing long lasting durable immunity. that's why the effectiveness has gone down from 90% to 40% to 50%. hospitalizations may not be going up yet, but i think the health and human services this week said they're worried this is just the tip of the spear. we're going to start seeing breakthrough hospitalizations. all of that data needs to be reviewed by acip to really look through the data because none of us have seen adequate amounts of data. that's point one. point two is when we talk about global vaccine equity, and i have devoted my life to developing vaccines for poverty-related and neglected diseases including a covid vaccine that our group at texas children's is now accelerating in india. india has produced -- starting to produce 100 million doses a month of that vaccine. i think the problem is we don't have enough mrna vaccine to go around. i mean the brand-new technology, there's a learning curve before you can scale it up and make billions of

the fda has given full approval to the coronavirus vaccine developed by pfizer and biontech.will now be marketed to the prevention of covid and people 16 and older. it is expected to boost confidence in the shot and may open the door to more vaccine mandates. pfizer will be required to assess the risks of myocarditis and peritonitis after vaccination. sales of previously owned homes rose in july. the u.s. and its allies have now flown more than 30,000 people out of afghanistan. boris johnson believes the americans may need to stay past their original departure date. bloomberg has learned the british prime minister will push president biden to extend the deadline passed august 31 so the evacuations can continue. the president has already suggested that might be necessary. global news 24 hours a day, on air and on bloomberg quicktake, powered by more than 2700 journalists and analysts in more than 120 countries. i'm ritika gupta. this is bloomberg. alix: by the debt -- buy the dip certainly there in europe. you have retailers leading the advance. so what do you do want to day l

biontech raised its forecast for vaccine sales to almost $19 billion. his partner pfizer filed contracts for 2.2 billion doses this year and more than one billion doses in 2022 and beyond. the vaccine is on track to be one of the best-selling drugs of all time, given biontech the cash push it needs to further r&d. let's take a look at the day ahead when it comes to australia and new zealand. it's census day industrial you. no shortage of controversy. questions of -- new south wales' chief health officer will be questioned over advice she provided to the government about sydney's lockdown at a special parliamentary inquiry. and challenger in james are set to report later. lots more ahead. shery: we can't go without checking the price of coffee. so, we're looking at coffee, and beans at a seven year high. brazil saying we could see a spike for the next two years, not boding well for the price of coffee. copper also at eight two week -- at a two week low. for a 4th consecutive month we saw copper and iron ore imports slumping. iron ore prices down. we cont

shery: pfizer and biontech are making headway toward getting a booster shot.wo companies submitted early-stage data showing a third shot of the vaccine given eight to nine months after the first two led to higher levels of antibodies. let's bring in the bloomberg opinion columnist. what is the composition of this word booster? how different is it from the first and second? my biggest concern, would it take away production capacity for the first two vaccines that are needed around the world? do we still have you with us? it seems we lost -- >> hi. shery: max is back. >> absolutely. the composition is the same as the first two rounds. it is the same vaccine. it is just another round. as for the concern about whether it might divert doses from elsewhere, there is no way around the fact it would, especially given the vaccination rate in africa and other parts of the world. even though we do have data that suggests this adds to protection. in some cases, it is justified. the u.s. approved before broader mr. schatz come a third dose for people immunocompromised who

naomi kresge joining us on what is going on at biontech today. increasingly looking like the boosters are going to be required. on the other hand, in the united states, we still need to vaccinate a lot of people. one of the themes i'm going to take away from this program is the u.s. feels-like it is falling further and further behind. you talk to ceos. that is where their concern is. alix: it is becoming so politicized now too that it feels like bridging the gap will feel quite tricky. those that need more information or help getting there or help understanding things is different, but very different indeed. we talked to mark bristow, who has been all over the world and said that in nevada, of all places, has the least amount of vaccinated workers versus chile at 100%. guy: a stunning revelation in terms of what is happening here. he is -- his people in close proximity. they have managed to do it elsewhere but not in the u.s. israel is talking about 40 and 50 euros getting booster shots so it feels like this will increasingly be an ongoing proces

pfizer, biontech and moderna covert shots cannot be used, but the fda says other fully vaccinated individualso not need a third dose. meanwhile, a u.s. supreme court judge has rejected a challenge to indiana universit'' requirement that alls students be vaccinated for covid for the coming semester. the case marks the first time the nation's highest court has ruled on a vaccine mandate. the pentagon says it is sending about 3000 extra u.s. troops to afghanistan to help evacuate clement -- evacuate diplomats. the u.s. currently has around 4000 people at its embassy, many of them american citizens. taliban fighters are reported to have captured the birthplace of the movement, and the second largest city in afghanistan. they were driven out of the city during the u.s. led invasion of 2001. police in plymouth and southwest england have confirmed six people, including a suspected gunman, have died in a firearms incident. three females, two males and a suspect died. no motive has yet been reported. murders committed by firearms average about 34 per year in the u.k. airbnb shares fell during late tra

corporate america is busting open the vaccine mandate floodgate after the fda approval to pfizer and biontechesident biden urge companies to mandate vaccines from employees disney announced it will require workers at walt disney world florida to be vaccinated against covid-19 covy october 2 disney will hold vaccine events for those employees. i hope it's more crowded than that video shows. chevron mandating vaccines for employees who traveled internationally in offshore workforce and the gulf of mexico and on shore support personnel popping 1.5% flipping it over to cvs health nurses, pharmacists and all employees who face patients to be jabbed by the end of next month that stock is down two thirds of 8% as corporations lay down the vaccine laws pfizer ceo telling fox news his team is hard at work to reach the next major milestone vaccine for elementary age children. >> five and 11 we will be able to finish in september. in a little bit later we will do for kids below five years old. liz: pfizer is not alone in what has to be the best case of corporate competition pfizer, moderna and j&j are i

in a tv interview today, he says the fire/biontech -- the pfizer/biontech and moderna vaccines couldead to lasting protection. what did he say? it really sets us up as we are trying to reopen schools and get to vaccine mandates. reporter: it is interesting he is saying they might not be needed indefinitely. they basically just decided that they are going to be needed. so i think there's still a lot of ground to be trod here in terms of what the research says and how people react to these shots. there haven't been extensive studies. we had a story friday about what the booster science is. certainly, it sounds like dr. fauci and health officials think these booster shots are going to be helpful. they've already decided that they have to be given to people with immune problems because these are the ones who have lower immune responses, but in the general population, i think there's a lot that remains to be seen here. of course, as you probably saw yesterday, the pfizer shop was approved. that probably opens the door to a number of mandates. next week we will be looking forward to what t

we're learning more from a senior federal official who says the pfizer biontech vaccine could get fda approval as soon as monday. that's big news for people who are on the front lines battling covid-19. i spoke with an emergency room doctor in jacksonville about this fda approval that's pending. he says this could be something he would put in his toolbox when he's going up against people who don't want to get the vaccine. you know what, nadia, we're facing disinformation. that's what we have to deal with all across social media, people who believe tiktok videos over him in his white coat and his many years of experience. those icu beds are filling up and in that particular hospital, they have an overflow hospital outside, like a mobile unit just in case. here in florida and texas where they have some of the highest numbers, the governors are pushing to take antibody treatments. it's only for if you have covid-19. when it comes to being proactive and limiting the spread with mask mandates, vaccines, social distancing, those governors are not supporting mask mandates. we're seeing that

. >>> pfizer/biontech vaccine gets full fda approval but is it enough to get unvaccinated americans on board. >>> and japan will host another athletic spectacle, we're live in tokyo for the paralympic games. good to have you with us. it remains to be seen if u.s. troops will stay in afghanistan past the august 31 deadline to help evacuate the thousands of people still trying to leave the country. g7 leaders are expected to pressure u.s. president biden to extend the mission during a virtual meeting a few hours from now. the uk defense secretary says it is unlikely but worth a try and u.s. military advisers have told the white house they need to know today if the deadline stands. the taliban want the americans out. >> we are well aware of the stated desire to -- by the taliban to have this mission completed by the 31st of august. i would tell you that we too are still planning on completing it by the 31st of august. that is the mission that has been assigned to us and that is what we're trying to execute. >> the u.s. says more than 16,000 people were evacuated sunday into monday, more t

we've gotbound tech up 1.4% -- biontech up about 1.4%. >>> covid testing and vaccinations ramping up's cleaning up those swabs and needles? the ceo of the company doing just that is next. with the closing bell ringing in 34 minutes, dow jones industrials still in the green by 53 points. s&p better by 11, that's a record. nasdaq up by 25, that too is a record. we are coming right back, don't go away. ♪ ♪ my name is douglas. i'm a writer/director and i'm still working. in the kind of work that i do, you are surrounded by people who are all younger than you. i had to get help somewhere along the line to stay competitive. i discovered prevagen. i started taking it and after a period of time, my memory improved. it was a game-changer for me. prevagen. healthier brain. better life. growing up in a little red house, on the edge of a forest in norway, there were three things my family encouraged: kindness, honesty and hard work. over time, i've come to add a fourth: be curious. be curious about the world around us, and then go. go with an open heart, and you will find inspiration anew. vikin

la agencia dice que todavÍa no es apropiado, y aunque la vacuna de pfizer biontech fue aprobada por completoyork ordena un mandato de vacunaciÓn en escuelas pÚblicas. es que todos los maestros tendrÁn que haber recibido una dosis de la vacuna contra el coronavirus para el 27 de septiembre. la decisiÓn impactarÍa a 148.000 empleados y contratistas que hacen parte del sistema escolar mÁs grande del paÍs. ♪ ♪ ♪ borja: y en nuestro segmento de mujeres al poder hablamos de kathy hochul, la primera mujer gobernadora de nueva york. tras la denuncia de andrew cuomo vamos escuchar. —— renuncia. [habla en inglÉs] borja: kathy hace historia y serÁ la primera mujer en ocupar este importante cargo. les cuento un poquito. ella ha sido vicegobernadora desde el 2015, aÑo en que fue nominada para esta posiciÓn por andrew cuomo. hochul tiene 18 aÑos de experiencia en la polÍtica previamente fue miembro de la cÁmara de representantes, desde bÚfalo, estÁ casada y tiene dos hijos. otra mujer haciendo historia. satsha: muy bien. vamos a lo siguiente, eduardo arellano fÉlix, ex lÍder del cÁrtel de tijuana ya estÁ

please explain >> as a state from healthcare the focus is on biontech we know there is bifurcation first, a table, what we know the total number of stocks in the spider's etf captures 195 there and you see $129 trillion. look at the look at the first comparative chart. two lines, one is the spider verses the i share this is an interesting diverse of a market cap etf for all intended purposes. the spread year to date is about 2500 basis you can see that there look at the next chart here are the two etfs again. this is the opportunity, look at the next three chart, this is the xbi and you can see the draw down that i annotated down to 30%. that 30% is exactly a 50% retracement from the pandemic low. you can see the line there then the final chart drawing the chart of support meaning a 30% sell-off a 50% trace of a move, right to the level that keeps holding we think the xbi is a circumstance of so bad it is good that it has a bounce potential here having sold off to support >> okay, bounce potential there on the xbi carter, thank you very much. mike, do you agree what if anything may be th

food and drug administration is expected to grant full approval of the pfizer-biontech vaccine as earlyunder 12 still are not eligible for vaccines and that makes some parents anxious. the rate of kids with covid under 19 is surging and a record number are in hospitals. still, debate rages over whether masks should be required in schools. cnn's evan mcmorris-santoro has more. >> reporter: this tampa 11-year-old had a strange first week of middle school. >> in two classes i had five kids quarantined. >> that seems like a lot. >> it is. >> scary? >> no, but one of my friends said that everyone around her was quarantined, so i'm pretty sure she was scared. >> are you worried you might be quarantined? >> maybe. >> reporter: at least 15 states have now mandated universal masking inside school buildings. following cdc guidelines for safer reopening amidst the delta surge. >> the masks are uncomfortable, but it's for safety. if i wear my mask, that means i get to see my friends. i'll just wear a mask. >> reporter: cdc data showing last week, the hospitalization rate for children is 33% higher

over 100 around the world taking part in the pfizer biontech clinical trials to evaluate the response to the covid-19 vaccine and children 12 and under and we're getting close to having. >> everyone i've gone getting both doses and then they watched for a couple months and that's where we need to get to before we can. they can submit the data to the fda for emergency use authorization. she says the phase one study is about finding the right dose for the right age group in size of children. >> and the phase. 2, 3, study is focused on the efficacy and the goal or what i understand the target will >> getting the data to the fda by the end of september. so hopefully by the end of october. if everything looks good, we should. you at. >> has menu in kron. 4 news. >> in the east bay, the city of concord in contra, costa county will bring a covid-19 vaccine clinic to the city's weekly music and market concert series starting thursday. the mobile clinic will offer a free johnson and johnson and pfizer biontech vaccines from 06:00pm to 08:00pm at santos plaza as well as moderna vaccines for peo

, we take a look at the past six reported quarters if you had simply shorted amgen and gone long biontech etf you would guarder a 12 point not very good performance. as we take a look at the fundamentals here, they may have a relatively high hurdle going into earnings. the company announced they were hindered by the pandemic in the first quarter. right now the consensus revenue estimate by analysts by about $6.5 million is the upper end of the company's own guidance, similarly if we look at op ex, which is a situation where the consensus view is for about a 12% increase where the company itself gotten in the mid teens, they have to deliver some good numbers for them to basicall basically outperform the consensus view i was thinking considering the fact that the stock is trading at a low key, about 4 right now. it is risky considering shorting a stock at that valuation. it is acting relatively i was looking at october that $20 costs about $6.35 less than the amount that the option market is implying the stock could move next week and about indeed as much as the stock moves as high from las

we have clear evidence of the safety and effectiveness of the pfizer/biontech vaccine. it's undergone full approval and full vetting by the gold standard, the u.s. fda. >> you used full there twice. the hate parade is already marching and saying they took shortcuts. this isn't real approval. they hedged it just to make you take it. do you believe any of that? >> no, i don't, chris. we heard from the fda today that the application for the pfizer/biontech, biological application license for full approval was over 300,000 pages. the fda career staff went through it, they did the number crunching, they know. so not only was this data in the clinical trial that was performed, but we have over several hundred million people around the world vaccinated with this vaccine. what does that tell you? that tells you that we have more data about efficacy and safety than almost any other vaccine in the history of vaccination. the data are clear. the fda has spoken. the vaccine is safe and effective. >> why isn't pfizer approved for 12 to 15? it's still under an emergency use authoriza

it's really important to point out that against hospitalizations or deaths, both the pfizer biontech vaccine and moderna vaccine, two doses is holding up really well the question is if there is a decline in asymptomatic transmission, should that warrant a boost? that's what the pfizer ceo said in a press release a few weeks ago but never presented the supporting data. and maybe that's the case. the question is if hospitalizations and deaths aren't affected, will that be enough to trigger the fda and cdc to want to move forward with that third immunization? that we don't have any clarity about. also, do we break it down by age groups in israel, we're giving third immunizations to individuals over the age of 60 is that the way the fda and cdc would go maybe when they make the announcement about immuno suppressive therapy, maybe they'll address other groups as well. >> for now, wear masks indoors, get vaccinated thanks so much. >>> we hear from the woman who is set to become new york's first female governor. she's set to start in 13 days when governor andrew cuomo says he will officiall

the fda has now granted full approval to the pfizer biontech covid-19 vaccine for people aged 16 andl approval by the fda. to this point, remember, it's been under what's known as emergency use authorization, still safe, and many millions of people have been vaccinated. however, big changes expected with this, include ing opening e door to more vaccine mandates. cnn's elizabeth cohen joins us now. i mean, in the scheme of things, this is pretty remarkable speed to get to full approval for a vaccine such as this. >> it is remarkable. they just started the clinical trials about 13 months ago. i mean, that is really amazing. people were talking, oh, it will take four or five years. they went from 13 months from starting the trial to full approval. that is really quite amazing. now, unfortunately, about a third of the united states hasn't seen it as amazing as this sort of medical miracle that we were given. some people see it as, wait a minute, that's a little too fast for my taste. i don't care that more than 40,000 people were involved in the clinical trial and that it was declared sa

biontech had to pivot away from personalized cancer drugs using mrna to focus on this vaccine. remarkable stuff. meg, appreciate it everybody, do not miss that. "a race against covid. you can find the documentary at cnbc.com and cnbc pages as well. worth the tcwah. >>> traders are making more moves in their portfolios. you're going to learn them next on "halftime." growing up in a little red house, on the edge of a forest in norway, there were three things my family encouraged: kindness, honesty and hard work. over time, i've come to add a fourth: be curious. be curious about the world around us, and then go. go with an open heart, and you will find inspiration anew. viking. exploring the world in comfort. >>> all right. your investment committee is making more moves in their portfolio. why are you adding to medtronic? >> so, for me, i was slightly underweight here on medtronic and just added additional capital. i really like their print. i think 19% organic revenue growth, 190 launch new products, which is a record for them i like health care in general. i think preventive car

over 100 around the world taking part in the pfizer biontech clinical trials to evaluate the response to the covid-19 vaccine and children 12 and under and we're getting close to having everyone have gone getting both doses and then being watched for a couple months. >> and that's where we need to get to before we can. they can submit the data to the fda for emergency use authorization. she says the phase one study is about finding the right dose for the right age group in size of children. >> and the phase. 2, 3, study is focused on the efficacy are you concerned that we're maybe 2, maybe 3 weeks in some cases into the new school year and we're hearing about transmissions of covid-19 in classroom settings. yeah. it's a tough one. i do think having kids come back together is important but maintain all of social distancing. >> and mask wearing and hand washing can really help with with transmissibility. i think we we have enough information watching the pandemic for the last 18 months to to feel like that. the benefits of getting back to school. far outweigh the risks. >> medical resea

pfizer and biontech submitted early stage critical trial data to the fda as they seek authorization for a booster for everyone 16 and older. and moderna's drop that we're seeing today comes after a stint of volatility as the stock got caught up in the reddit trade. it is now down 24% on the week stu still up more than 120% on a year-to-date basis >> i was just going to ask, we're now down 24% in the past week in moderna? wow. that's quite a turn a-round. thank you. the record market rally is also taking a breather as the fed moves up its taper timeline to possibly as soon as next month in terms of the announcement so if we have a faster fed what names should you buy now that will continue to outperform? david katz is chief investment officer at matrix asset advisers david, welcome i'll resist the temptation to say but what if they don't taper and let's just start with the premise that they will and what you think people should buy. >> well, i think the one group that's going to do very well during a taper environment and when interest rates are moving up are the financials. they've had

the fda granting full approval of unifiedpfizer/biontech vacci.or joining us, dr. divan. so pfizer shares up more than 3% this was largely expected that they would ultimately get this full approval by the fda is it kind of a pull forward and timing that the market is excited about? >> yeah, thanks for having me on a couple of things i'd say one, getting the certainty that it came through. maybe a little bit earlier than people were expecting. obviously, we have seen the stock do very, very well the past few weeks in anticipation of this. i think also just general news around the booster opportunity has got a lot of play in the stock. and then a small ac sis morning. people liking that they are putting the cash to use. a number of factors. obviously, the approval is the big news for sure. >> does it hang your modeling at all? because i saw that your current price target is $43 a share, which is about 16% discount to where the hairs are trading in today. how are you factoring in the delta variant, need for bus boosters, approval for children under t

that adds to yesterday's rally sparked by the fda giving full approval to pfizer and biontech's vaccine. stocks jumped because the at and more companies to mandate the shots amid the spread of the deltahan 200 point yesterday and the nasdaq closed at a record high. today we're focused on a report on new home sales and earnings from best buy. president biden will meet with ceos of several tech companies tomorrow to discuss how they're improving cyber security following a spike in data breaches and ransomware attacks since the pandemic. bloomberg reports tim cook, microsoft's ceo satya nadella and amazon's new chief andy jassy will attend. the heads of ibm, google, jp morgan chase have been invite pd. they will discuss how software can drive better security and protect the supply chain overall. >>> ford is doubling production fort f-150 lightning because of strong early demand for the electric pick-up truck ahead of its launch next year. reuters reports ford plans to spend $850 million to meet demand. industry watchers have questioned whether buyers are willing to give up gas powered truc

over 100 around the world taking part in the pfizer biontech clinical trials to evaluate the response to the covid-19 vaccine in children, 12 and under and we're getting close to having everyone have gone getting both doses and then being watched for a couple months. >> and that's where we need to get to before we can. they can submit the data to the fda for emergency use authorization. she says the phase one study is about finding the right dose for the right age group in size of children. >> and the phase. 2, 3, study is focused on the efficacy. are you concerned that we're maybe 2, maybe 3 weeks in some cases into the new school year and we're hearing about transmissions of covid-19 in classroom settings. yeah. it's a tough one. i do think having kids come back together is important but maintain all of social distancing. >> and mask wearing and hand washing can really help with with francis ability. i think we we have enough information watching the pandemic for the last 18 months to to feel like that. the benefits of getting back to school. our >> medical researchers at stafford s

over 100 around the world taking part in the pfizer biontech clinical trials to evaluate the response to the covid-19 vaccine and children 12 and under and we're getting close to having everyone have gone getting both doses and then they watched for a couple months and that's where we need to get to before we can. they can submit the data to the fda for >> emergency use authorization. she says the phase one study is about finding the right dose for the right age group in size of children. >> and the phase. 2, 3, study is focused on the efficacy are you concerned that we're maybe 2, maybe 3 weeks in some cases into the new school year and we're hearing about transmissions of covid-19 in classroom settings. yeah. it's a tough one. i do think having kids come back together is important but maintain all of social distancing. >> and mask wearing and hand washing can really help with with transmissibility. i think we we have enough information watching the pandemic for the last 18 months to to feel like that. the benefits of getting back to school. are i weigh the risks. >> medical research

today pfizer and biontech sent initial data on boosters to the fda and the pharmaceutical companies say their findings support the use of a booster dose for their train 19 vaccine. >>> the number of vaccinated californians is rising. 78.3% of eligible residents have received at least one covid shot. more than 45 million doses have been administered statewide. and coming up at 5:30, we are going to chat with a ucsf dr. about a drop in the state's positivity rate and whether he believes that trend will continue. >>> within the past hour we have learned about dozens of covid cases in the oakland unified school district. 68 students and staffers have now tested positive. officials closed a classroom at montclair elementary and one at oakland high as a precaution, but they believe the cases were contracted from outside of the schools. >> at this point we have no reason to believe that there is community transmission within the classroom. we've not yet seen that. is it possible that it's going to happen sometime in the district 2 it sure is possible but we are doing everything we can to preve